Empowering The Future Of Medicine

Bringing transformative medicines to market requires a manufacturing partner capable of navigating the intricate transition from molecule to medicine. Advanced therapies, including large molecule biologics and cell-based treatments, demand a "right-first-time" culture to ensure patient safety and regulatory success. By leveraging a sustainable North American network, developers can access end-to-end capabilities that span cell line development, drug substance production, and aseptic drug product manufacturing.

Efficiency in this space is defined by speed without compromising quality. Advanced facilities now offer rapid batch release timelines—such as eight days for cell therapy and twenty days for commercial manufacturing—to keep pace with clinical and market demands. Integrated digital quality management systems provide the transparency needed to de-risk regulatory filings while maintaining control over complex processes like microbial fermentation and autologous CAR-T platforms. Accessing these scalable solutions allows biopharma partners to deliver life-changing treatments to global markets with consistent reliability.